Ampyra
Need help?
Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.
What Is Ampyra?
Ampyra, also known by its generic name dalfampridine, is an extended-release prescription medication approved by the U.S. Food and Drug Administration (FDA) to improve walking ability in patients with multiple sclerosis (MS). MS is a chronic autoimmune disease that affects the central nervous system, causing a range of symptoms, including muscle weakness and difficulty with coordination and balance. Ampyra works by blocking certain potassium channels in nerve cells, which helps to improve the conduction of nerve signals along damaged nerve fibers. By enhancing nerve impulse transmission, this medication can potentially improve walking speed and mobility in individuals with MS. It's important to note that Ampyra is not a cure for MS, nor does it slow down the progression of the disease. Its primary goal is to improve walking ability and increase the patient's quality of life. As with any medication, Ampyra may cause side effects, such as seizures, urinary tract infections, and dizziness. It should only be used under the guidance and prescription of a healthcare professional who can assess its benefits and risks for each individual patient.
How to use Ampyra?
Ampyra, also known as dalfampridine, is a prescription medication used to improve walking ability in patients with multiple sclerosis (MS). It is an extended-release tablet that should be taken orally, usually twice a day with or without food. To use Ampyra effectively, here are some important instructions: 1. Follow the dosage instructions provided by your healthcare provider. Do not take more or less medication than prescribed. 2. Swallow the tablet whole. Do not crush, chew, or break it, as it is formulated as an extended-release medication. 3. Take Ampyra at approximately the same times each day to maintain a consistent level of the drug in your system. 4. If you miss a dose, skip the missed dose and resume your regular dosing schedule. Do not double up on doses to make up for a missed one. 5. Be cautious when using Ampyra in combination with other medications, as drug interactions may occur. Inform your healthcare provider about all the medications you are currently taking. 6. It may take time to experience the full benefits of Ampyra. Be patient and continue taking the medication as prescribed. 7. Regularly communicate with your doctor regarding any changes in your symptoms or concerns about the medication's effectiveness or side effects. Remember, Ampyra is specifically for improving walking ability in MS patients and is not a cure for the disease. It is essential to consult with your healthcare provider for proper guidance and monitoring throughout your treatment with Ampyra.
There are several warnings associated with the use of Ampyra (dalfampridine). This medication is an extended-release tablet that is specifically prescribed to improve walking ability in patients with multiple sclerosis (MS). First and foremost, it's important to note that Ampyra is contraindicated for patients with a history of seizures, as it can lower the seizure threshold and increase the risk of seizures. Therefore, it should not be used in individuals with a seizure disorder or a history of seizure-related conditions. Additionally, patients with moderate to severe kidney impairment should exercise caution when using Ampyra, as the drug is predominantly eliminated through the kidneys. Reduced kidney function can lead to higher drug levels in the body, potentially increasing the risk of adverse effects. It is crucial to follow the prescribed dosage and not exceed the recommended dose of Ampyra, as higher doses can increase the risk of seizures and other unwanted side effects. It's important to inform your healthcare provider about any other medications you may be taking, as certain drug interactions can also increase the risk of seizures and other adverse events. Finally, Ampyra may cause an increase in blood pressure, so individuals with hypertension or a history of cardiovascular problems should be monitored closely while taking this medication. As always, it's crucial to discuss any concerns or potential risks with your healthcare provider before starting or stopping any medication, including Ampyra.
Before taking Ampyra (dalfampridine), there are several important warnings and precautions to be aware of. Firstly, it is vital to inform your healthcare provider about any existing medical conditions, including kidney problems or seizures. Ampyra can increase the risk of seizures, so it may not be suitable for individuals with a history of seizures or who are prone to experiencing them. Additionally, Ampyra should not be taken together with other forms of 4-aminopyridine (4-AP) due to the potential for overdose. This includes compounded 4-AP medications, as the active ingredient is the same as in Ampyra. It is worth noting that some individuals may experience an allergic reaction to Ampyra, which can manifest as difficulty breathing, hives, or swelling of the face, lips, tongue, or throat. If such symptoms occur, emergency medical attention should be sought. Lastly, Ampyra does not cure multiple sclerosis (MS) nor does it address other symptoms associated with the condition. Its purpose is solely to improve walking ability in individuals with MS. It is important to work closely with your healthcare provider to determine if Ampyra is appropriate for your specific situation and to discuss potential risks and benefits.
Some common side effects of Ampyra (also known by its generic name, dalfampridine) may include: 1. Seizures: This is the most serious side effect of Ampyra, and it can occur even if the individual has never had a seizure before. Patients with a history of seizures should exercise caution when using this medication. 2. Urinary tract infections: Some individuals may experience an increased risk of urinary tract infections while taking Ampyra. This can manifest as frequent urination, painful urination, or cloudy urine. 3. Dizziness: Dizziness is a common side effect of Ampyra. It may be mild or severe and can make it difficult to maintain balance and coordination. It's important to be cautious when performing activities that require concentration and alertness, such as driving or operating machinery. 4. Insomnia: Some people may experience difficulty sleeping or staying asleep while taking Ampyra. This can lead to daytime sleepiness and fatigue. It's best to take the medication in the morning to minimize its impact on sleep. 5. Nausea: Ampyra can cause feelings of nausea or stomach discomfort in certain individuals. Taking the medication with food may help alleviate this side effect. 6. Headache: Headaches are a potential side effect of Ampyra. If the headaches become severe or persistent, it's important to consult a healthcare professional. It's worth noting that these are not the only side effects associated with Ampyra. Patients should consult their healthcare provider for a comprehensive list and to discuss any specific concerns or questions they may have.
The active ingredient in Ampyra is dalfampridine. It is an extended-release tablet that is specifically prescribed for patients with multiple sclerosis (MS) who experience difficulty walking. Dalfampridine is a potassium channel blocker, which means it works by improving the conduction of nerve signals along damaged nerves in the legs. By doing so, it may enhance walking speed and mobility in individuals with MS. Aside from the active ingredient, Ampyra tablets also contain other ingredients, known as excipients, which are necessary for the formulation and manufacturing of the medication. These excipients include components such as colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol, talc, and titanium dioxide. It is important to note that Ampyra should only be taken under the supervision of a healthcare professional, as it may interact with other medications or have potential side effects. As with any medication, it is essential to follow the prescribed dosage and consult with a healthcare provider for personalized guidance.
Ampyra, also known as dalfampridine, is an extended-release prescription medication specifically indicated for patients with multiple sclerosis (MS) to improve their ability to walk. When it comes to the storage of Ampyra, it's important to follow the specific guidelines provided by the manufacturer and your healthcare professional. Generally, Ampyra should be stored at room temperature, away from excessive heat and moisture. It is recommended to keep the medication in its original tightly closed container to protect it from light and humidity. It should be stored in a secure place, out of the reach of children and pets. Additionally, it is crucial to never transfer Ampyra to another container, as it might lead to a loss of effectiveness or cause confusion with other medications. If you have any expired or unused Ampyra medication, it's important to dispose of it properly according to local regulations or consult with your pharmacist for guidance. Remember, always consult with your healthcare professional or pharmacist for specific storage instructions for Ampyra, as they may vary based on the manufacturer's guidelines and any additional considerations for your particular situation.
Similar Drugs
Our philosophy is simple — hire a team of diverse, passionate people and foster a culture that empowers you to do your best